Volume 95 Issue 29 | p. 17 | Concentrates
Issue Date: July 17, 2017

Lilly and Purdue sign R&D agreement

Department: Business
Keywords: research, collaboration, Lilly, Purdue
[+]Enlarge
Lilly will work with Purdue researchers on drug delivery and predictive modeling.
Credit: Purdue
A photo of researchers at Purdue University.
 
Lilly will work with Purdue researchers on drug delivery and predictive modeling.
Credit: Purdue

Eli Lilly & Co. and Purdue University have formed a five-year pact to develop injectable drug delivery technology and models to predict the therapeutic outcomes of new medicines. Lilly will pay up to $52 million over the term of the contract, making the deal Purdue’s largest collaboration with a single company. Purdue researchers in natural and physical sciences, engineering, and veterinary medicine will work with Lilly. Last year the university announced a plan to invest $250 million in life sciences research. Purdue President Mitchell E. Daniels Jr. is the former head of Lilly’s North American drug operation.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment